IL1B and atherosclerosis: IL-1β is a key cytokine in atherosclerosis, and IL-1β-/- mice were reported to have a 30% reduction in the size of atherosclerotic plaques compared with the control group, in addition, monoclonal antibodies against IL-1β inhibit plaque formation in apo E-/- mice (87).